AGL logo

agilon health (AGL)

Profile

Full Name

agilon health, inc.

Ticker Symbol

AGL

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 15, 2021

Indexes

Not included

Website

http://www.agilonhealth.com

Employees

1076

Key Details

Price

$5.54(+0.27%)

Market cap

$2.29B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$6.06B(+40.41% YoY)

Annual EPS

-$0.63(+1.56% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.54
AGL price is $5.54

30-Day Relative Volume

0.76
AGL 30-day relative volume is 0.76

Price Performance

Price Today change

+0.27%
AGL price is up +0.27% today

Price YTD change

+191.84%
AGL price is up +191.84% since January 1st

Price 1-year change

+23.77%
AGL price is up +23.77% year-on-year

Price 3-year change

-75.96%
AGL price is down -75.96% over the past 3 years

Price Range

Price All-time high

$44.83
AGL price is currently -87.63% below its historical high of $44.83

Price 3-year low

$1.50
AGL price is currently +269.67% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.29B
AGL market capitalization is $2.29 billion

Market cap 3-year change

-75.57%
AGL market capitalization is down -75.57% over the past 3 years

Market cap All-time high

$16.90B
AGL market capitalization is currently -86.47% below its historical high of $16.90 billion

Market cap sector rank

84.38%
AGL market capitalization is higher than 84.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.3%
AGL shares outstanding is up +0.3% year-on-year

Shares Outstanding 3-Year Change

+1.63%
AGL shares outstanding is up +1.63% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.05
AGL beta is -0.05

200-day SMA

$3.77
AGL price is currently +47.05% above its 200-day simple moving average

50-day SMA

$4.00
AGL price is currently +38.60% above its 50-day simple moving average

RSI

70.36
AGL 14-day relative strength index is 70.36

Volume

0.76
AGL 30-day relative volume is 0.76

ATR

$0.41
AGL average true range is $0.41

10-day Historical Volatility

135.43%
AGL 10-day historical volatility is 135.43%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$6.06B
AGL annual revenue is $6.06 billion

Revenue Analysts estimate

$6.00B
AGL annual revenue is currently +1.07% higher than the consensus analysts' forecast

Revenue 1-year change

+40.41%
AGL annual revenue is up +40.41% year-on-year

Revenue Sector rank

92.63%
AGL annual revenue is higher than 92.63% of companies in Healthcare sector

EPS

EPS

-$0.63
AGL annual earnings per share is -$0.63

EPS Analysts estimate

-$0.32
AGL annual earnings per share is currently +100.00% higher than the consensus analysts' forecast

EPS 1-year change

+1.56%
AGL annual earnings per share is up +1.56% year-on-year

EPS Sector rank

64.54%
AGL annual earnings per share is higher than 64.54% of companies in Healthcare sector

Profit

Gross profit

$4.84M
AGL annual gross profit is $4.84 million

Gross margin

0.08%
AGL annual gross profit margin is 0.08%

Operating profit

-$288.53M
AGL annual operating income is -$288.53 million

Operating margin

-4.76%
AGL annual operating profit margin is -4.76%

Net income

-$260.15M
AGL annual net profit is -$260.15 million

Net margin

-4.29%
AGL annual net profit margin is -4.29%

Expenses

Total expenses

$6.35B
AGL annual total expenses is $6.35 billion

Operating expenses

$293.38M
AGL annual total operating expenses is $293.38 million

Cost of goods sold

$6.06B
AGL annual cost of goods sold is $6.06 billion

Selling, general & administrative expenses

$268.91M
AGL annual SGA is $268.91 million

Depreciation and amortization

$24.46M
AGL annual depreciation & amortization is $24.46 million

Interest expense

$6.18M
AGL annual interest expense is $6.18 million

Income tax

$1.45M
AGL annual income tax is $1.45 million

EBIT & EBITDA

EBIT

-$242.65M
AGL annual earnings before interest & taxes is -$242.65 million

EBITDA

-$218.19M
AGL annual EBITDA is -$218.19 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.73B
AGL annual total assets is $1.73 billion

Non current assets

$276.21M
AGL annual long term assets is $276.21 million

Current assets

$1.46B
AGL annual total current assets is $1.46 billion

Cash and cash equivalents

$188.23M
AGL annual cash & cash equivalents is $188.23 million

Accounts receivable

$1.02B
AGL annual accounts receivable is $1.02 billion

Inventory

-
AGL annual inventory value is unknown

Liabilities

Total liabilities

$1.26B
AGL annual total liabilities is $1.26 billion

Long term liabilities

$111.03M
AGL annual total long term liabilities is $111.03 million

Current liabilities

$1.15B
AGL annual total current liabilities is $1.15 billion

Accounts payable

$1.15B
AGL annual accounts payable is $1.15 billion

Debt

Total debt

$41.50M
AGL annual total debt is $41.50 million

Total debt 1-year change

-3.96%
AGL annual total debt is down -3.96% year-on-year

Long term debt

$41.50M
AGL annual long term debt is $41.50 million

Short term debt

-
AGL annual short term debt value is unknown

Equity & Capital

Shareholders equity

$470.95M
AGL annual stockholders equity is $470.95 million

Book value

$470.95M
AGL annual book value is $470.95 million

Retained earnings

-$1.59B
AGL annual retained earnings is -$1.59 billion

Working capital

$305.77M
AGL annual working capital is $305.77 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$57.78M
AGL annual cash flow from operations is -$57.78 million

Cash from operations 1-year change

+63.01%
AGL annual cash flow from operations is up +63.01% year-on-year

Cash from investing

$139.89M
AGL annual cash flow from investing activities is $139.89 million

Cash from investing 1-year change

+417.8%
AGL annual cash flow from investing activities is up +417.8% year-on-year

Cash from financing

-$2.58M
AGL annual cash flow from financing activities is -$2.58 million

Cash from financing 1-year change

+98.66%
AGL annual cash flow from financing activities is up +98.66% year-on-year

CAPEX

CAPEX

$41.28M
AGL annual capital expenditures is $41.28 million

CAPEX 1-year change

+33.98%
AGL annual capital expenditures is up +33.98% year-on-year

Free Cash Flow

Free cash flow

-$99.06M
AGL annual free cash flow is -$99.06 million

Free cash flow 1-year change

+47.03%
AGL annual free cash flow is up +47.03% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

0.08%
AGL annual gross profit margin is 0.08%

Operating margin

-4.76%
AGL annual operating profit margin is -4.76%

Net margin

-4.29%
AGL annual net profit margin is -4.29%

ROA & ROE

ROA

-14.97%
AGL annual return on assets is -14.97%

ROE

-45.96%
AGL annual return on equity is -45.96%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AGL price to earnings ratio value is unknown

PE ratio Sector rank

-
AGL price to earnings ratio is unknown

PB Ratio

PB ratio

4.85
AGL price to book ratio is 4.85

PB ratio Sector rank

82.3%
AGL price to book ratio is higher than 82.3% of companies in Healthcare sector

PS Ratio

PS ratio

0.38
AGL price to sales ratio is 0.38

PS ratio Sector rank

13.21%
AGL price to sales ratio is higher than 13.21% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.14B
AGL enterprise value is $2.14 billion

Enterprise value Sector rank

82.71%
AGL enterprise value is higher than 82.71% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-9.81
AGL EV/EBITDA is -9.81

EV/EBITDA Sector rank

11.05%
AGL EV/EBITDA is higher than 11.05% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.27
AGL annual current ratio is 1.27

Quick ratio

-
AGL annual quick ratio value is unknown

Leverage

Debt to equity

0.07
AGL annual debt to equity ratio is 0.07

Interest coverage ratio

-39.28
AGL annual interest coverage ratio is -39.28

Risk & Stability

Piotroski F-Score

4
AGL piotroski f-score is 4

Altman Z-Score

3.05
AGL altman z-score is 3.05

Analyst ratings

Recent major analysts updates

Apr 8, 25 Bernstein
Outperform
Mar 21, 25 Needham
Hold
Feb 26, 25 Stifel
Hold
Feb 26, 25 RBC Capital
Outperform
Feb 26, 25 Needham
Hold
Feb 26, 25 Citizens Capital Markets
Market Perform
Jan 15, 25 Bernstein
Market Perform
Jan 10, 25 Needham
Hold
Jan 10, 25 Citigroup
Neutral
Dec 16, 24 Macquarie
Neutral

Institutional Ownership

Similar stocks

RXRX logo
Recursion Pharmaceuticals (RXRX)
ACHC logo
Acadia Healthcare (ACHC)
CERT logo
Certara (CERT)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
AMRX logo
Amneal Pharmaceuticals (AMRX)
TWST logo
Twist Bioscience (TWST)
IBRX logo
ImmunityBio (IBRX)
APLS logo
Apellis Pharmaceuticals (APLS)
FOLD logo
Amicus Therapeutics (FOLD)
  • What is the ticker symbol for agilon health?
  • Does agilon health pay dividends?
  • What sector is agilon health in?
  • What industry is agilon health in?
  • What country is agilon health based in?
  • When did agilon health go public?
  • Is agilon health in the S&P 500?
  • Is agilon health in the NASDAQ 100?
  • Is agilon health in the Dow Jones?
  • When was agilon health's last earnings report?
  • When does agilon health report earnings?
  • Should I buy agilon health stock now?

What is the ticker symbol for agilon health?

The ticker symbol for agilon health is NYSE:AGL

Does agilon health pay dividends?

No, agilon health does not pay dividends

What sector is agilon health in?

agilon health is in the Healthcare sector

What industry is agilon health in?

agilon health is in the Medical Care Facilities industry

What country is agilon health based in?

agilon health is headquartered in United States

When did agilon health go public?

agilon health's initial public offering (IPO) was on April 15, 2021

Is agilon health in the S&P 500?

No, agilon health is not included in the S&P 500 index

Is agilon health in the NASDAQ 100?

No, agilon health is not included in the NASDAQ 100 index

Is agilon health in the Dow Jones?

No, agilon health is not included in the Dow Jones index

When was agilon health's last earnings report?

agilon health's most recent earnings report was on Feb 25, 2025

When does agilon health report earnings?

The next expected earnings date for agilon health is May 6, 2025

Should I buy agilon health stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page